Position in VTRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$627,434
+$53,759 QoQ
Shares Held
39,511
-7.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#375
of 1,020 holders
Holding Since
Mar 2021
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Vestmark Advisory Solutions, Inc. holds $12,974,406 across 11 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
351,770 | $5,638,872 | |
| 2 | HLN |
Haleon plc
|
314,017 | $2,929,778 | |
| 3 | ANIP |
Ani Pharmaceuticals Inc
|
16,440 | $1,360,903 | |
| 4 | ALKS |
Alkermes plc.
|
15,829 | $829,439 | |
| 5 | VTRS |
Viatris Inc
This page
|
39,511 | $627,434 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
23,600 | $580,796 | |
| 7 | ZTS |
Zoetis Inc.
|
7,289 | $523,787 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
9,069 | $307,257 |
All Filings in VTRS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $627,434 | 39,511 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $573,675 | 42,463 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $422,030 | 33,898 | Shares | Other | 2026-02-06 | |
| 2025-09-30 | $238,986 | 24,140 | Shares | Other | 2025-11-10 | |
| 2023-06-30 | $144,041 | 14,433 | Shares | Sole | 2023-08-07 | |
| 2021-12-31 | $407,388 | 30,110 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $342,828 | 25,301 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $330,470 | 23,126 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $276,829 | 19,816 | Shares | Sole | 2021-05-10 | |
| No filing history on record for this holder in this stock. | ||||||